Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NanoGuardian, a division of NanoInk, has entered into a license agreement with Capsugel, a division of Pfizer and and a provider of capsule-based drug delivery systems, that gives Capsugel global access to NanoGuardian's NanoEncryption technology for the protection of capsule-based medications against counterfeiting and illegal diversion.
Subscribe to our email newsletter
NanoGuardian’s NanoEncryption technology works directly on capsules, tablets, vial caps, and single-use syringes to provide a layered security strategy consisting of overt, covert and forensic security features.
NanoGuardian said that its multi-layered security provides a dual-protective benefit to manufacturers by fighting both counterfeiting and illegal diversion with a single technology. The overt and covert security features allow dose-level authentication at any point in a manufacturer’s supply chain, while forensic NanoCodes provide comprehensive tracing information on each and every dose.
The company claimed that its technology provides a strong benefit over other on-dose technologies given that NanoGuardian’s security features are implemented with no additional chemicals being added to the medication.
In addition to the traditional NanoGuardian model of using a proprietary machine to implement the NanoEncryption technology, Capsugel is expected to offer pre-NanoEncrypted capsule shells to pharmaceutical companies, eliminating any additions to their current manufacturing process. Capsugel will market this new technology to current and future Capsugel customers and expects it to be able to supply NanoEncrypted capsules by mid-2010.
Guido Driesen, president and general manager of Capsugel, said: “Capsugel is committed to providing advancements in capsule dosage delivery technology. Given the concerning rise in counterfeit and illegally diverted medications throughout the world, we wanted to bring value to our customers by helping to protect their brands, companies, and the patients they serve. After evaluating available security technologies, we chose NanoGuardian as a technology partner because of the sophistication, sustainability and benefits of their NanoEncryption technology. This will allow our pharmaceutical customers to authenticate and trace every single dose, from plant-to-patient,”
James Hussey, chief executive officer of NanoGuardian, said: Together, NanoGuardian and Capsugel can extend product security and integrity to the dose level for capsule-based medications and help provide confidence to the millions of patients who rely on these medications for their health and well being.”